Abstract

Mutations in the transcription factor methyl-CpG-binding protein 2 (MeCP2) cause the neurodevelopmental disorder Rett syndrome (RTT). Besides many other neurological problems, RTT patients show irregular breathing with recurrent apneas or breath-holdings. MeCP2-deficient mice, which recapitulate this breathing phenotype, show a dysregulated, persistent expression of G-protein-coupled serotonin receptor 5-ht5b (Htr5b) in the brainstem. To investigate whether the persistence of 5-ht5b expression is contributing to the respiratory phenotype, we crossbred MeCP2-deficient mice with 5-ht5b-deficient mice to generate double knockout mice (Mecp2−/y;Htr5b−/−). To compare respiration between wild type (WT), Mecp2−/y and Mecp2−/y;Htr5b−/− mice, we used unrestrained whole-body plethysmography. While the breathing of MeCP2-deficient male mice (Mecp2−/y) at postnatal day 40 is characterized by a slow breathing rate and the occurrence of prolonged respiratory pauses, we found that in MeCP2-deficient mice, which also lacked the 5-ht5b receptor, the breathing rate and the number of pauses were indistinguishable from WT mice. To test for a potential mechanism, we also analyzed if the known coupling of 5-ht5b receptors to Gi proteins is altering second messenger signaling. Tissue cAMP levels in the medulla of Mecp2−/y mice were decreased as compared to WT mice. In contrast, cAMP levels in Mecp2−/y;Htr5b−/− mice were indistinguishable from WT mice. Taken together, our data points towards a role of 5-ht5b receptors within the complex breathing phenotype of MeCP2-deficient mice.

Highlights

  • The neurodevelopmental Rett syndrome (RTT) occurs primarily in females with an incidence of 1:10,000 live births and presents as a delayed regression after 6–18 months of apparently normal development (Rett, 1966; Julu et al, 2001)

  • cAMP signaling must be seen in the context

  • Our data supports the notion that 5-ht5b-receptor dysregulation is an important

Read more

Summary

Introduction

The neurodevelopmental Rett syndrome (RTT) occurs primarily in females with an incidence of 1:10,000 live births and presents as a delayed regression after 6–18 months of apparently normal development (Rett, 1966; Julu et al, 2001). Male patients rather show hypoventilation, apneas and respiratory insufficiency soon after birth (Geerdink et al, 2002; Kankirawatana et al, 2006; Schüle et al, 2008). The male Mecp2−/y null mice, which are the original model to analyze the loss of MeCP2 in neurons, have a characteristic impairment of breathing (Guy et al, 2001), which manifests as hypoventilation, with a reduced respiratory rate and minute ventilation together with a high number of apneas (Viemari et al, 2005; Chao et al, 2010; Wegener et al, 2014). The ultimate cause of altered respiratory behavior is not yet known and might very well be different in male and female subjects. It is clear that breathing of MeCP2 deficient mice is influenced by many factors that include neurotransmitter systems like norepinephrine (Viemari et al, 2005) or neurotrophic factors like BDNF (Li and Pozzo-Miller, 2014) as well as cellular systems like glia cells (Lioy et al, 2011; Delépine et al, 2015) and inhibitory neurons (Hülsmann et al, 2016)

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call